Development of quantitative method for determination of γ-glutamyl peptides by capillary electrophoresis tandem mass spectrometry: An efficient approach avoiding matrix effect

Journal of Chromatography A

Volumn 1369, Issue , 2014, Pages 161-169

  Hirayama, Akiyoshi ^a   Igarashi, Kaori ^a   Tomita, Masaru ^a   Soga, Tomoyoshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Capillary electrophoresis tandem mass spectrometry (CE MS MS); Liquid chromatography tandem mass spectrometry (LC MS MS); Liver disease; Matrix effect; Glutamyl peptides

Indexed keywords

CAPILLARY ELECTROPHORESIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

LIMITS OF DETECTION; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); LIVER DISEASE; MATRIX EFFECTS; MULTIPLE REACTION MONITORING; QUANTITATIVE METHOD; REVERSE-PHASE COLUMN; TANDEM MASS SPECTROMETRY;

PEPTIDES;

3 AMINOPYRROLIDINE; DIPEPTIDE; GAMMA GLUTAMYLALANINE; GAMMA GLUTAMYLARGININE; GAMMA GLUTAMYLASPARAGINE; GAMMA GLUTAMYLASPARTIC ACID; GAMMA GLUTAMYLCITRULLINE; GAMMA GLUTAMYLGLUTAMINE; GAMMA GLUTAMYLGLYCINE; GAMMA GLUTAMYLHISTIDINE; GAMMA GLUTAMYLHOMOCYSTEINE; GAMMA GLUTAMYLHOMOSERINE GLYCINE; GAMMA GLUTAMYLISOLEUCINE; GAMMA GLUTAMYLLEUCINE; GAMMA GLUTAMYLLYSINE; GAMMA GLUTAMYLMETHIONINE; GAMMA GLUTAMYLNORVALINE GLYCINE; GAMMA GLUTAMYLORNITHINE; GAMMA GLUTAMYLPHENYLALANINE; GAMMA GLUTAMYLSERINE; GAMMA GLUTAMYLSERYLGLYCINE; GAMMA GLUTAMYLTHREONINE; GAMMA GLUTAMYLVALINE; GAMMA GLUTAMYLVALYLGLYCINE; GLUTAMIC ACID DERIVATIVE; METHIONINE SULFONE; PYRROLIDINE DERIVATIVE; THIOL; TRIPEPTIDE; UNCLASSIFIED DRUG; PEPTIDE;

ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS C; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; LIVER PARENCHYMA; MEASUREMENT ACCURACY; PEPTIDE ANALYSIS; PROCESS MONITORING; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; CHEMISTRY; LIVER; PH; PROCEDURES; REPRODUCIBILITY;

CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, CAPILLARY; HUMANS; HYDROGEN-ION CONCENTRATION; LIVER; PEPTIDES; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84911991922     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.10.007     Document Type: Article

References (25)

1. Soga T., Baran R., Suematsu M., Ueno Y., Ikeda S., Sakurakawa T., Kakazu Y., Ishikawa T., Robert M., Nishioka T., Tomita M. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 2006, 281:16768-16776.
2. Soga T., Sugimoto M., Honma M., Mori M., Igarashi K., Kashikura K., Ikeda S., Hirayama A., Yamamoto T., Yoshida H., Otsuka M., Tsuji S., Yatomi Y., Sakuragawa T., Watanabe H., Nihei K., Saito T., Kawata S., Suzuki H., Tomita M., Suematsu M. Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J. Hepatol. 2011, 55:896-905.
3. Hu L., Li X., Jiang X., Zhou H., Jiang X., Kong L., Ye M., Zou H. Comprehensive peptidome analysis of mouse livers by size exclusion chromatography prefractionation and nano LC-MS/MS identification. J. Proteome Res. 2007, 6:801-808.
4. Petritis K., Brussaux S., Guenu S., Elfakire C., Dreux M. Ion-pair reversed-phase liquid chromatography-electrospray mass spectrometry for the analysis of underivatized small peptides. J. Chromatogr. A 2002, 957:173-185.
5. Buscher J.M., Czernik D., Ewald J.C., Sauer U., Zamboni N. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal. Chem. 2009, 81:2135-2143.
6. Mant C.T., Cepeniene D., Hodges R.S. Reversed-phase HPLC of peptides: assessing column and solvent selectivity on standard, polar-embedded and polar endcapped columns. J. Sep. Sci. 2010, 33:3005-3021.
7. Ohsawa K., Satsu H., Ohki K., Enjoh M., Takano T., Shimizu M. Producibility and digestibility of antihypertensive beta-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. J. Agric. Food. Chem. 2008, 56:854-858.
8. Zhang T., Creek D.J., Barrett M.P., Blackburn G., Watson D.G. Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with orbitrap mass spectrometry for metabolomic studies of human urine. Anal. Chem. 2012, 84:1994-2001.
9. Kloepfer A., Quintana J.B., Reemtsma T. Operational options to reduce matrix effects in liquid chromatography-electrospray ionization-mass spectrometry analysis of aqueous environmental samples. J. Chromatogr. A 2005, 1067:153-160.
10. Hirayama A., Kami K., Sugimoto M., Sugawara M., Toki N., Onozuka H., Kinoshita T., Saito N., Ochiai A., Tomita M., Esumi H., Soga T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009, 69:4918-4925.
11. Ishii N., Nakahigashi K., Baba T., Robert M., Soga T., Kanai A., Hirasawa T., Naba M., Hirai K., Hoque A., Ho P.Y., Kakazu Y., Sugawara K., Igarashi S., Harada S., Masuda T., Sugiyama N., Togashi T., Hasegawa M., Takai Y., Yugi K., Arakawa K., Iwata N., Toya Y., Nakayama Y., Nishioka T., Shimizu K., Mori H., Tomita M. Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science 2007, 316:593-597.
12. Soga T., Ohashi Y., Ueno Y., Naraoka H., Tomita M., Nishioka T. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2003, 2:488-494.
13. Sugimoto M., Wong D.T., Hirayama A., Soga T., Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010, 6:78-95.
14. Soga T., Ishikawa T., Igarashi S., Sugawara K., Kakazu Y., Tomita M. Analysis of nucleotides by pressure-assisted capillary electrophoresis-mass spectrometry using silanol mask technique. J. Chromatogr. A 2007, 1159:125-133.
15. Dams R., Huestis M.A., Lambert W.E., Murphy C.M. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J. Am. Soc. Mass Spectrom. 2003, 14:1290-1294.
16. Maurer H.H. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin. Biochem. 2005, 38:310-318.
17. Bonfiglio R., King R.C., Olah T.V., Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 1999, 13:1175-1185.
18. Gustavsson E., Andersson M., Stephanson N., Beck O. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing. J. Mass Spectrom. 2007, 42:881-889.
19. Chambers E., Wagrowski-Diehl D.M., Lu Z., Mazzeo J.R. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 2007, 852:22-34.
20. Ismaiel O.A., Halquist M.S., Elmamly M.Y., Shalaby A., Thomas Karnes H. Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations. J. Chromatogr. B 2008, 875:333-343.
21. Soga T., Heiger D.N. Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. Anal. Chem. 2000, 72:1236-1241.
22. Toyo'oka T. Recent advances in separation and detection methods for thiol compounds in biological samples. J. Chromatogr. B 2009, 877:3318-3330.
23. D'Agostino L.A., Lam K.P., Lee R., Britz-McKibbin P. Comprehensive plasma thiol redox status determination for metabolomics. J. Proteome Res. 2011, 10:592-603.
24. Zhu P., Oe T., Blair I.A. Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide. Rapid Commun. Mass Spectrom. 2008, 22:432-440.
25. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009, 29(Suppl. 1):74-81.